| Accession | IsolateName | Country | Coll Date | Clone | MolType | Source | Note | FirstAA | LastAA | MutList |
|---|
| PQ511497 | GB1LV100004 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511498 | GB1LV100005 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511501 | GB1LV100008 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511502 | GB1LV100009 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 19 | 231 | 19R,21K,22Q,28K,82K,83L,127E,132K,133*,180D,194S,230I |
| PQ511503 | GB1LV100010 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511504 | GB1LV100011 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 19 | 231 | 19R,21K,22Q,28K,82K,83L,127E,132K,133*,180D,194S,230I |
| PQ511505 | GB1LV100012 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 19 | 231 | 19R,21K,22Q,28K,82K,83L,127E,132K,133*,180D,194S,230I |
| PQ511506 | GB1LV100013 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511508 | GB1LV100015 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511509 | GB1LV100016 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60E,80*,83L,96I,117*,127R,156R,167Q,180D,184*,194S,206R,222R,230I |
| PQ511513 | GB1LV100020 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,117*,156R,162K,180D,184*,194S,213K,230I |
| PQ511514 | GB1LV100021 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511515 | GB1LV100022 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511516 | GB1LV100023 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,133*,180D,194S,213K,230I |
| PQ511517 | GB1LV100024 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511518 | GB1LV100025 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,139K,180D,194S,230I |
| PQ511520 | GB1LV100027 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511522 | GB1LV100029 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,28K,60E,80*,83L,100K,117*,133*,167Q,180D,184*,194S,214I,222R,230I |
| PQ511523 | GB1LV100030 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,80*,83L,100K,127R,156R,180D,184*,194S,230I |
| PQ511525 | GB1LV100032 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,14P,80*,83L,96I,117*,127E,143K,156R,180D,184*,194S,206R,230I |
| PQ511526 | GB1LV100033 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,14P,80*,83L,96I,117*,127E,143K,156R,180D,184*,194S,206R,230I |
| PQ511528 | GB1LV100035 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511529 | GB1LV100036 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511532 | GB1LV100039 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511533 | GB1LV100040 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511537 | GB1LV100044 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511539 | GB1LV100046 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511540 | GB1LV100047 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,127R,156R,180D,184*,194S,230I |
| PQ511541 | GB1LV100048 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511542 | GB1LV100049 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511543 | GB1LV100050 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,76K,83L,98K,101E,132K,180D,194S,230I |
| PQ511544 | GB1LV100051 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511546 | GB1LV100053 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,127R,156R,180D,184*,194S,230I |
| PQ511547 | GB1LV100054 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511548 | GB1LV100055 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511549 | GB1LV100056 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511550 | GB1LV100057 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511551 | GB1LV100058 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,127R,156R,180D,184*,194S,230I |
| PQ511552 | GB1LV100059 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511553 | GB1LV100060 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511554 | GB1LV100061 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511555 | GB1LV100062 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,173K,180D,194S,230I |
| PQ511557 | GB1LV100064 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,212K,230I |
| PQ511558 | GB1LV100065 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511560 | GB1LV100067 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,127R,156R,180D,184*,194S,230I |
| PQ511561 | GB1LV100068 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,212K,230I |
| PQ511562 | GB1LV100069 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511563 | GB1LV100070 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511566 | GB1LV100073 | | 2023 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511570 | GB1LV100077 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511571 | GB1LV100078 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Intact;Days post-infection: 28years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511572 | GB1LV100079 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,10I,14P,23*,80*,83L,89R,98K,101R,116K,117*,127R,133*,143K,156R,162K,180D,184*,194S,206R,213K,220R,222R,223R,230I |
| PQ511575 | GB1LV100082 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,10I,14P,23*,60R,80*,83L,137R,180D,194S,230I |
| PQ511577 | GB1LV100084 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511578 | GB1LV100085 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.5 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,29K,81N,82K,83L,133*,137E,180D,194S,230I |
| PQ511579 | GB1LV100086 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,60R,80*,83L,116E,133*,137R,143K,156R,162K,180D,184*,194S,230I |
| PQ511580 | GB1LV100087 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 19.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511582 | GB1LV100089 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,46R,80*,83L,97K,106R,117*,162K,180D,184*,194S,206R,223R,225S,229K,230I |
| PQ511583 | GB1LV100090 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,10I,14P,23*,29K,46R,51N,60K,80*,83L,89R,96I,97K,101R,116R,117*,127R,133*,137R,156R,167Q,180D,184*,194S,206R,222R,223R,230I |
| PQ511584 | GB1LV100091 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,127R,156R,180D,184*,194S,230I |
| PQ511585 | GB1LV100092 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,29K,83L,128K,133*,137E,180D,194S,212K,213K,230I |
| PQ511586 | GB1LV100093 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,106R,116R,117*,132K,133*,180D,194S,230I |
| PQ511587 | GB1LV100094 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,106R,116R,117*,132K,133*,180D,194S,230I |
| PQ511588 | GB1LV100095 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (premature stopcodon);Days post-infection: 28 years;Pt ID: P1042;Pt HLAtype: HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511589 | GB1LV100096 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511590 | GB1LV100097 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,28K,75K,80*,83L,89R,97K,100K,101E,106R,117*,133*,143K,180D,184*,194S,206R,229K,230I |
| PQ511591 | GB1LV100098 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,60R,80*,83L,116R,156R,167Q,180D,184*,194S,230I |
| PQ511592 | GB1LV100099 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,83L,180D,194S,230I |
| PQ511594 | GB1LV100101 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,116R,117*,127R,133*,180D,184*,194S,230I |
| PQ511596 | GB1LV100103 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511597 | GB1LV100104 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,106R,116R,117*,132K,133*,180D,194S,230I |
| PQ511598 | GB1LV100105 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60E,80*,83L,96I,117*,127R,156R,167Q,180D,184*,194S,206R,222R,230I |
| PQ511600 | GB1LV100107 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (large deletion);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,17L,23*,60E,80*,83L,96I,117*,127R,156R,167Q,180D,184*,194S,206R,222R,230I |
| PQ511601 | GB1LV100108 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,106R,116R,117*,132K,133*,180D,194S,230I |
| PQ511603 | GB1LV100110 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,117*,133*,180D,194S,230I |
| PQ511604 | GB1LV100111 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,117*,133*,180D,184*,194S,206R,230I |
| PQ511605 | GB1LV100112 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,106R,116R,117*,132K,133*,180D,194S,230I |
| PQ511606 | GB1LV100113 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (internalinversion);Days post-infection: 28 years;Pt ID: P1042;PtHLA type: HLA-A*26:08, HLA-A*30:02, HLA-B*18:01,HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511608 | GB1LV100115 | | 2023 | | genomic DNA | CD4+ Cells | Viral intactness: Defective (hypermutation);Dayspost-infection: 28 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,10I,14P,23*,60K,80*,83L,89E,106R,116R,117*,127R,133*,156R,167Q,180D,184*,194S,206R,230I |
| PQ511609 | GB1LV100116 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,29K,81N,82K,83L,133*,137E,180D,194S,230I |
| PQ511610 | GB1LV100117 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511612 | GB1LV100119 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,96I,100K,117*,133*,167Q,180D,184*,194S,206R,223R,230I |
| PQ511613 | GB1LV100120 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511616 | GB1LV100123 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,60E,80*,83L,100K,117*,143K,156R,180D,184*,194S,230I |
| PQ511617 | GB1LV100124 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (5 prime defect);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,71K,76V,83L,127E,180D,194S,230I |
| PQ511618 | GB1LV100125 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511619 | GB1LV100126 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (5 prime defect);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,71K,76V,83L,127E,180D,194S,230I |
| PQ511620 | GB1LV100127 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,116R,180D,184*,194S,220R,230I |
| PQ511622 | GB1LV100129 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511623 | GB1LV100130 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,101R,117*,127R,133*,180D,184*,194S,230I |
| PQ511624 | GB1LV100131 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,75K,83L,180D,194S,230I |
| PQ511625 | GB1LV100132 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511626 | GB1LV100133 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511627 | GB1LV100134 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,117*,133*,137R,143K,167Q,180D,184*,194S,230I |
| PQ511628 | GB1LV100135 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (5 prime defect);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,20F,37L,45A,72A,83L,86L,180D,194S,230I |
| PQ511629 | GB1LV100136 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (5 prime defect);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,20F,37L,45A,72A,83L,86L,180D,194S,230I |
| PQ511631 | GB1LV100138 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511632 | GB1LV100139 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511633 | GB1LV100140 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,29K,60R,80*,83L,89R,156R,180D,184*,194S,222R,223R,230I |
| PQ511634 | GB1LV100141 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,61E,83L,116E,127E,128K,133*,159K,162K,166N,180D,187K,194S,230I |
| PQ511635 | GB1LV100142 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60R,80*,83L,116R,117*,167Q,180D,184*,194S,222R,230I |
| PQ511636 | GB1LV100143 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60E,80*,83L,89R,101R,117*,133*,137R,180D,184*,194S,222R,230I |
| PQ511637 | GB1LV100144 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 20 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,103N,128K,132K,180D,194S,230I |
| PQ511638 | GB1LV100145 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511639 | GB1LV100146 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511640 | GB1LV100147 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,60R,80*,83L,100K,117*,127R,137R,143K,180D,184*,194S,206R,223R,230I |
| PQ511641 | GB1LV100148 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,133*,180D,194S,212K,220E,230I |
| PQ511642 | GB1LV100149 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511643 | GB1LV100150 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511644 | GB1LV100151 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,10I,14P,23*,60R,80*,83L,117*,156R,180D,184*,194S,229K,230I |
| PQ511645 | GB1LV100152 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511646 | GB1LV100153 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511647 | GB1LV100154 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511648 | GB1LV100155 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,82S,83L,180D,194S,230I |
| PQ511649 | GB1LV100156 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511650 | GB1LV100157 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511651 | GB1LV100158 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,97K,101E,117*,127R,133*,137R,180D,184*,194S,222R,230I |
| PQ511652 | GB1LV100159 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511653 | GB1LV100160 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,101R,117*,127R,133*,180D,184*,194S,230I |
| PQ511654 | GB1LV100161 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,100K,101R,167Q,180D,184*,194S,213K,230I |
| PQ511655 | GB1LV100162 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511656 | GB1LV100163 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511657 | GB1LV100164 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,80*,83L,162K,180D,194S,206R,230I |
| PQ511658 | GB1LV100165 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511659 | GB1LV100166 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511660 | GB1LV100167 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,75K,83L,98K,116E,118I,127E,132K,133*,162K,166N,180D,194S,230I |
| PQ511661 | GB1LV100168 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,106R,116R,117*,132K,133*,180D,194S,230I |
| PQ511662 | GB1LV100169 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,101R,127R,180D,184*,194S,223R,230I |
| PQ511663 | GB1LV100170 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (5 prime defect);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,18K,28K,29K,83L,98K,128K,132K,133*,159K,162K,180D,184*,187K,194S,214I,220K,230I |
| PQ511664 | GB1LV100171 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (5 prime defect);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511665 | GB1LV100172 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,28K,46R,60K,79K,80*,83L,89K,116R,117*,127R,128K,132K,133*,137R,143K,162K,175K,180D,184*,194S,220E,222R,223R,225S,230I |
| PQ511666 | GB1LV100173 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,14P,23*,80*,83L,116R,117*,127E,133*,137R,143K,167Q,180D,184*,194S,223R,230I |
| PQ511667 | GB1LV100174 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,28K,46R,60K,79K,80*,83L,89K,116R,117*,127R,128K,132K,133*,137R,143K,162K,175K,180D,184*,194S,220E,222R,223R,225S,230I |
| PQ511668 | GB1LV100175 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,116R,117*,133*,143K,156R,180D,184*,194S,230I |
| PQ511669 | GB1LV100176 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60R,61R,80*,83L,116R,117*,127R,133*,137R,156R,180D,184*,194S,212K,220R,222R,230I |
| PQ511670 | GB1LV100177 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,14P,23*,60K,80*,83L,117*,133*,143K,156R,167Q,180D,184*,194S,220R,223R,230I |
| PQ511671 | GB1LV100178 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,14P,23*,60E,80*,83L,137R,180D,184*,194S,220R,230I |
| PQ511672 | GB1LV100179 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511673 | GB1LV100180 | | 2015 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 20years;Pt ID: P1042;Pt HLA type: HLA-A*26:08, HLA-A*30:02,HLA-B*18:01, HLA-B*39:01, HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511674 | GB1LV100181 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,28K,46E,75K,80*,81N,83L,96I,97K,98K,117*,128K,132K,133*,166N,180D,184*,194S,206E,212K,213K,214I,215I,222E,223K,230I |
| PQ511675 | GB1LV100182 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 20 years;Pt ID: P1042;Pt HLA type:HLA-A*26:08, HLA-A*30:02, HLA-B*18:01, HLA-B*39:01,HLA-C*05:01, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511676 | GB1LV100183 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,83L,180D,194S,197N,222R,230I |
| PQ511677 | GB1LV100184 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,116R,117*,180D,184*,194S,206R,220R,222R,230I |
| PQ511678 | GB1LV100185 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 20 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,46E,60E,71K,80*,83L,101R,116R,117*,133*,143K,156R,167Q,180D,184*,194S,230I |
| PQ511679 | GB1LV100186 | | 2015 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 20 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511681 | GB1LV100188 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60E,61R,80*,83L,89R,97K,100K,116R,117*,127R,133*,137R,143K,156R,167Q,180D,184*,194S,206R,220R,222R,230I |
| PQ511682 | GB1LV100189 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511683 | GB1LV100190 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511684 | GB1LV100191 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511685 | GB1LV100192 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511686 | GB1LV100193 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 12 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60R,80*,83L,100K,106E,116R,117*,180D,184*,194S,230I |
| PQ511687 | GB1LV100194 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511688 | GB1LV100195 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511689 | GB1LV100196 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511690 | GB1LV100197 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511691 | GB1LV100198 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511692 | GB1LV100199 | | 2007 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 12 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,133*,180D,194S,213K,230I |
| PQ511693 | GB1LV100200 | | 2007 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 12years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511694 | GB1LV100201 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511695 | GB1LV100202 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511696 | GB1LV100203 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511697 | GB1LV100204 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511698 | GB1LV100205 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511699 | GB1LV100206 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511700 | GB1LV100207 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511701 | GB1LV100208 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511702 | GB1LV100209 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511703 | GB1LV100210 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511704 | GB1LV100211 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,10I,14P,18K,23*,60E,80*,83L,100K,116R,117*,156R,167Q,180D,184*,194S,206R,222R,223R,230I |
| PQ511705 | GB1LV100212 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,96I,117*,143K,162K,180D,184*,194S,206R,220R,230I |
| PQ511706 | GB1LV100213 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,60E,80*,83L,100K,116R,117*,127R,133*,180D,184*,194S,230I |
| PQ511707 | GB1LV100214 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,62Y,80*,83L,100K,117*,127R,180D,184*,194S,230I |
| PQ511708 | GB1LV100215 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,101R,117*,127R,137R,167Q,180D,184*,194S,222R,230I |
| PQ511709 | GB1LV100216 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511710 | GB1LV100217 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511711 | GB1LV100218 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511712 | GB1LV100219 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,116K,117*,128K,133*,137E,162K,180D,184*,194S,206R,212K,230I |
| PQ511713 | GB1LV100220 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511714 | GB1LV100221 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,82K,83L,97K,101E,113K,128K,133*,137E,162K,163N,180D,194S,214I,230I |
| PQ511715 | GB1LV100222 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,14P,23*,80*,83L,97K,117*,127K,133*,180D,184*,194S,229K,230I |
| PQ511716 | GB1LV100223 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511717 | GB1LV100224 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511718 | GB1LV100225 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511719 | GB1LV100226 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511720 | GB1LV100227 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511721 | GB1LV100228 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,100K,127R,133*,156R,163N,173K,180D,184*,194S,214I,230I |
| PQ511722 | GB1LV100229 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,46E,80*,83L,101R,127R,143K,156R,180D,184*,194S,222R,230I |
| PQ511723 | GB1LV100230 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511724 | GB1LV100231 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511725 | GB1LV100232 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,80*,83L,101R,117*,156R,180D,184*,194S,230I |
| PQ511726 | GB1LV100233 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511727 | GB1LV100234 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511728 | GB1LV100235 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511729 | GB1LV100236 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511730 | GB1LV100237 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511731 | GB1LV100238 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511732 | GB1LV100239 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511733 | GB1LV100240 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511734 | GB1LV100241 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511735 | GB1LV100242 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,8R,14P,23*,46R,60R,80*,83L,96I,100K,101E,106R,117*,133*,137R,143K,180D,184*,194S,220R,225S,230I |
| PQ511736 | GB1LV100243 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,80*,83L,89R,116R,117*,127R,133*,143K,180D,184*,194S,206R,223R,230I |
| PQ511737 | GB1LV100244 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,29K,80*,83L,117*,127R,128K,133*,156R,159K,163N,180D,184*,194S,212K,222R,223E,230I |
| PQ511738 | GB1LV100245 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,18K,29K,31T,75K,76K,83L,96I,117*,132K,133*,137K,156E,159K,162K,163N,166N,173K,180N,194S,197N,212K,213K,214I,230I |
| PQ511739 | GB1LV100246 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511740 | GB1LV100247 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511741 | GB1LV100248 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511742 | GB1LV100249 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511743 | GB1LV100250 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511744 | GB1LV100251 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511745 | GB1LV100252 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511746 | GB1LV100253 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (large deletion);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,28K,60R,80*,83L,89R,97K,117*,133*,137E,143K,156R,167Q,180D,184*,194S,206R,213K,214I,220E,222R,230I |
| PQ511747 | GB1LV100254 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511748 | GB1LV100255 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,71K,79K,83L,133*,180D,194S,230I |
| PQ511749 | GB1LV100256 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,60R,71K,80*,83L,97K,101R,117*,133*,137R,180D,184*,194S,221I,230I |
| PQ511750 | GB1LV100257 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,10I,14P,23*,46R,80*,83L,89R,96I,100K,101R,117*,133*,137R,143K,156R,162K,180D,184*,194S,222R,230I |
| PQ511751 | GB1LV100258 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511752 | GB1LV100259 | | 1995 | | genomic DNA | PBMC | Viral intactness: Intact;Days post-infection: 0.6years;Pt ID: P1043;Pt HLA type: HLA-A*11:01, HLA-A*26:08,HLA-B*39:01, HLA-B*51:01, HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,83L,180D,194S,230I |
| PQ511753 | GB1LV100260 | | 1995 | | genomic DNA | PBMC | Viral intactness: Defective (hypermutation);Dayspost-infection: 0.6 years;Pt ID: P1043;Pt HLA type:HLA-A*11:01, HLA-A*26:08, HLA-B*39:01, HLA-B*51:01,HLA-C*05:03, HLA-C*12:03;subtype: B | 1 | 231 | 6L,14P,23*,60K,80*,83L,100K,117*,143K,156R,180D,184*,194S,230I |
